|
11-gene set, overall survival
|
|
Median of risk score
|
1.425
|
1.073
|
1.892
|
0.0143
|
|
Gender
|
1.460
|
0.926
|
2.300
|
0.1031
|
|
Age
|
1.037
|
1.022
|
1.052
|
<0.0001
|
|
Stage (0.1.2 vs. 3.4)
|
2.990
|
2.185
|
4.092
|
<0.0001
|
|
11-gene set, disease-free survival
|
|
Median of risk score
|
1.341
|
0.997
|
1.803
|
0.0521
|
|
Gender
|
1.485
|
0.930
|
2.371
|
0.0974
|
|
Age
|
1.036
|
1.020
|
1.051
|
<0.0001
|
|
Stage (0.1.2 vs. 3.4)
|
2.941
|
2.116
|
4.087
|
<0.0001
|
|
5-gene set, overall survival
|
|
Median of risk score
|
1.414
|
1.063
|
1.882
|
0.0172
|
|
Gender
|
1.455
|
0.923
|
2.293
|
0.1060
|
|
Age
|
1.037
|
1.022
|
1.052
|
<0.0001
|
|
Stage (0.1.2 vs. 3.4)
|
2.922
|
2.134
|
3.999
|
<0.0001
|
|
5-gene set, disease-free survival
|
|
Median of risk score
|
1.356
|
1.009
|
1.823
|
0.0435
|
|
Gender
|
1.489
|
0.933
|
2.375
|
0.0950
|
|
Age
|
1.036
|
1.021
|
1.051
|
<0.0001
|
|
Stage (0.1.2 vs. 3.4)
|
2.903
|
2.087
|
4.037
|
<0.0001
|
